NewAmsterdam Pharma NAMS Q1 2026 Earnings Narrowerthanexpected loss as biotech advances pipeline TSS Inc TSSI Q1 2026 Earnings EPS Surges 170 Above Estimates Revenue Data Unavailable GROV Q1 2026 Earnings Strong EPS Beat Highlights Cost Discipline Arch Capital Group Q1 2026 Earnings EPS Misses Consensus by a Small Margin Shares Edge Higher Maison Solutions MSS Q1 2026 Earnings Significant EPS Miss Overshadows Quarter VNO Q1 2026 Earnings EPS Misses Estimates as Office Sector Pressures Persist